染色体外DNA扩增促进小细胞肺癌异质性并与更差预后相关
该研究整合全基因组测序、长程光学图谱、单细胞DNA测序和荧光原位杂交,发现染色体外DNA(ecDNA)是小细胞肺癌(SCLC)致癌基因扩增和驱动融合的主要来源。ecDNA使增强子元件与致癌基因邻近,形成SCLC转录扩增单元,驱动极高的MYC基因剂量。研究证明无细胞核小体谱分析可在血浆中无创检测ecDNA扩增,且携带复杂ecDNA扩增的SCLC生存结局显著更差。
要点
- ecDNA是SCLC致癌基因扩增和驱动融合的主要来源,可驱动极高的MYC基因剂量。
- ecDNA使增强子元件与致癌基因邻近,形成转录扩增单元,促进肿瘤可塑性和异质性。
- 无细胞核小体谱分析可在血浆中无创检测ecDNA扩增;复杂ecDNA扩增者生存显著更差。
核心结论
- ecDNA扩增作为MYC扩增单元发挥作用,促进肿瘤可塑性和高度肿瘤异质性,ecDNA介导的转录灵活性可能解释携带复杂ecDNA扩增的SCLC生存结局显著更差。
研究设计与样本
- 研究整合全基因组测序、长程光学图谱、单细胞DNA测序和荧光原位杂交,并以SCLC为范式。
主要发现
- ecDNA是SCLC致癌基因扩增和驱动融合的主要来源,使增强子元件与致癌基因邻近,形成SCLC转录扩增单元,驱动极高的MYC基因剂量。
- 无细胞核小体谱分析可在血浆中无创检测ecDNA扩增,便于在SCLC及其他癌症中开展全基因组探究。
- 携带复杂ecDNA扩增的SCLC生存结局显著更差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Small-cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer. Oncogenic MYC amplifications drive SCLC heterogeneity, but the genetic mechanisms of MYC amplification and phenotypic plasticity, characterized by neuroendocrine and nonneuroendocrine cell states, are not known. Here, we integrate whole-genome sequencing, long-range optical mapping, single-cell DNA sequencing, and fluorescence in situ hybridization to find extrachromosomal DNA (ecDNA) as a primary source of SCLC oncogene amplifications and driver fusions. ecDNAs bring to proximity enhancer elements and oncogenes, creating SCLC transcription-amplifying units, driving exceptionally high MYC gene dosage. We demonstrate that cell-free nucleosome profiling can noninvasively detect ecDNA amplifications in plasma, facilitating its genome-wide interrogation in SCLC and other cancers. Altogether, our work provides the first comprehensive map of SCLC ecDNA and describes a new mechanism that governs MYC-driven SCLC heterogeneity. ecDNA-enabled transcriptional flexibility may explain the significantly worse survival outcomes of SCLC harboring complex ecDNA amplifications. SIGNIFICANCE: MYC drives SCLC progression, but the genetic basis of MYC-driven SCLC evolution is unknown. Using SCLC as a paradigm, we report how ecDNA amplifications function as MYC-amplifying units, fostering tumor plasticity and a high degree of tumor heterogeneity. This article is highlighted in the In This Issue feature, p. 799.
引用
- Pongor LS, Schultz CW, Rinaldi L, et al. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes. Cancer Discov. 2023. PMID: 36715552. doi:10.1158/2159-8290.CD-22-0796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。